Kisho

Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy

neuroleptic malignant syndrome (NMS) - Clinical Profile, Genes & Research | Kisho | Kisho

Rare Disease

neuroleptic malignant syndrome

MONDO:0019790

Also known as:NMS

Overview

Neuroleptic malignant syndrome (NMS) is an idiosyncratic condition associated with administration of antipsychotic and other central dopaminergic blockers, and characterized by hyperthermia, muscular rigidity, autonomic dysfunction and altered consciousness.

Patient Orgs1 organizations · Neuroleptic Malignant Syndrome Information Service, Inc.

Diagnosis

Biomarker and diagnostic research for neuroleptic malignant syndrome has been reported in the published literature.

Prognosis

Estimated prevalence: Unknown (Unknown prevalence).

Research Landscape

Sourced from ClinicalTrials.gov and PubMed. Publication types are classified using NLM-curated article metadata; research type breakdowns reflect the nature of published work for this disease.

No clinical trials have been registered for neuroleptic malignant syndrome.

145 publications have been identified in PubMed for neuroleptic malignant syndrome. Kisho has analyzed 107 by research type. Research spans Case Report / Case Series (55%), Review / Meta-Analysis (21%), and Epidemiology / Natural History (11%).

Research Type	Count	% of Total
Patient case studies	59	55%

Data assembled from 3 of 12 sources · Last updated Sep 18, 2026, 9:33 PM UTC

MONDOHPOClinicalTrials.govFDAPubMedHGNCClinVarClinGenGeneReviewsOrphanetOMIMRUSP

Patient Support

Patient Advocacy Groups

View all PAGs →

Neuroleptic Malignant Syndrome Information Service, Inc.Primary Focus

USWebsite ↗

Patient Advocacy Groups (PAGs) provide support, resources, and community for patients and caregivers.

Are you a patient organization not listed here? Claim this page to be listed and embed this content on your site — free.

Medical References

External Resources

Orphanet

European rare disease database

Orphanet:94093

GARD

Genetic and Rare Diseases Info Center

GARD:7195

Questions for Your Care Team

→Are there specialists or centers of excellence for this condition in my area?
→How can I connect with Neuroleptic Malignant Syndrome Information Service, Inc. and other patient organizations for support?

← Back to All Diseases

neuroleptic malignant syndrome

Overview

Diagnosis

Prognosis

Research Landscape

Patient Support

Patient Advocacy Groups

Medical References

External Resources

Orphanet

GARD

Related Diseases

Questions for Your Care Team

Questions for Your Care Team

Recent Publications